152 related articles for article (PubMed ID: 27579036)
1. Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers.
Negovan A; Iancu M; Moldovan V; Voidazan S; Bataga S; Pantea M; Sarkany K; Tatar C; Mocan S; Banescu C
Gastroenterol Res Pract; 2016; 2016():7230626. PubMed ID: 27579036
[TBL] [Abstract][Full Text] [Related]
2. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
[TBL] [Abstract][Full Text] [Related]
4. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
5. Statins and gastroduodenal endoscopic lesions: A case-control study.
Pantea M; Negovan A; Voidăzan S; Macarie M; Mocan S; Băţagă S
Medicine (Baltimore); 2018 Dec; 97(50):e13579. PubMed ID: 30558024
[TBL] [Abstract][Full Text] [Related]
6. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
7. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
[TBL] [Abstract][Full Text] [Related]
8. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use.
Iijima K; Shimosegawa T
Curr Pharm Des; 2015; 21(35):5056-65. PubMed ID: 26369687
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin.
Pilotto A; Franceschi M; Longoa MG; Scarcelli C; Orsitto G; Perri FC; D'Ambrosio LP; Leandro G
Dig Liver Dis; 2004 Oct; 36(10):666-70. PubMed ID: 15506665
[TBL] [Abstract][Full Text] [Related]
11. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
12. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
Chan FK
Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
[TBL] [Abstract][Full Text] [Related]
13. Bleeding gastroduodenal ulcers in patients without Helicobacter pylori infection and without exposure to non-steroidal anti-inflammatory drugs.
Smolović B; Stanisavljević D; Golubović M; Vucković L; Milicić B; Djuranović S
Vojnosanit Pregl; 2014 Feb; 71(2):183-90. PubMed ID: 24665577
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and nonsteroidal anti-inflammatory drugs.
Chan FK
Gastroenterol Clin North Am; 2001 Dec; 30(4):937-52. PubMed ID: 11764536
[TBL] [Abstract][Full Text] [Related]
15. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
16. [Role of Helicobacter pylori infection and use of NSAIDs in the etiopathogenesis of upper gastrointestinal bleeding].
Sokić-Milutinović A; Krstić M; Popović D; Mijalković N; Djuranović S; Culafić Dj
Acta Chir Iugosl; 2007; 54(1):51-62. PubMed ID: 17633863
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin.
Hsu PI; Tsai TJ
Curr Pharm Des; 2015; 21(35):5049-55. PubMed ID: 26369688
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with gastro-duodenal ulcer in compensated type 2 diabetic patients: a Romanian single-center study.
Negovan A; Banescu C; Pantea M; Simona B; Mocan S; Iancu M
Arch Med Sci; 2022; 18(1):45-51. PubMed ID: 35154524
[TBL] [Abstract][Full Text] [Related]
19. Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding.
Stack WA; Atherton JC; Hawkey GM; Logan RF; Hawkey CJ
Aliment Pharmacol Ther; 2002 Mar; 16(3):497-506. PubMed ID: 11876703
[TBL] [Abstract][Full Text] [Related]
20. Peptic Ulcer Bleeding Risk. The Role of Helicobacter Pylori Infection in NSAID/Low-Dose Aspirin Users.
Sostres C; Carrera-Lasfuentes P; Benito R; Roncales P; Arruebo M; Arroyo MT; Bujanda L; García-Rodríguez LA; Lanas A
Am J Gastroenterol; 2015 May; 110(5):684-9. PubMed ID: 25895518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]